Letter: Natural oestrogens and antithrombin-III levels.
作者信息
Greig H B, Notelowitz M
出版信息
Lancet. 1975 Feb 15;1(7903):412-3. doi: 10.1016/s0140-6736(75)91350-1.
PMID:46578
Abstract
摘要
相似文献
1
Letter: Natural oestrogens and antithrombin-III levels.信函：天然雌激素与抗凝血酶III水平
Lancet. 1975 Feb 15;1(7903):412-3. doi: 10.1016/s0140-6736(75)91350-1.
2
An in vivo system in man for quantitation of estrogenicity. II. Pharmacologic changes in binding capacity of serum corticosteroid-binding globulin induced by conjugated estrogens, mestranol, and ethinyl estradiol.人体中用于定量雌激素活性的体内系统。II. 共轭雌激素、炔雌醇甲醚和炔雌醇诱导的血清皮质类固醇结合球蛋白结合能力的药理学变化。
Am J Obstet Gynecol. 1978 Feb 15;130(4):482-6.
3
Conjugated estrogens and hypercoagulability.
Am J Obstet Gynecol. 1975 Jul 15;122(6):688-92. doi: 10.1016/0002-9378(75)90572-4.
4
Massive hyperlipemia during estrogen therapy.雌激素治疗期间出现的严重高脂血症。
JAMA. 1974 Feb 4;227(5):522-5.
5
[A new estrogen variant in the oral contraceptive Non-Ovlon].
Dtsch Gesundheitsw. 1973;28(5):223-7.
6
Effect of oestrogens on human platelet behaviour.雌激素对人体血小板行为的影响。
Lancet. 1968 Aug 10;2(7563):315-8. doi: 10.1016/s0140-6736(68)90528-x.
7
Orally active oestrogens and progestins in prevention of pregnancy in rats.口服活性雌激素和孕激素对大鼠的避孕作用
J Reprod Fertil. 1969 Apr;18(3):509-15. doi: 10.1530/jrf.0.0180509.
8
[Proceedings: Antithrombin 3 during use of oral contraceptives].[会议论文：口服避孕药使用期间的抗凝血酶Ⅲ]
Arch Gynakol. 1973 Sep 28;214(1):264-5. doi: 10.1007/BF00671129.
9
Antithrombin 3 and oestrogen content of oral contraceptives.口服避孕药中的抗凝血酶3和雌激素含量。
Lancet. 1973 Apr 14;1(7807):831. doi: 10.1016/s0140-6736(73)90634-x.
10
Plasma protein changes induced by sequential type of contraceptive steroid pills.序贯型避孕甾体激素药丸引起的血浆蛋白变化
Clin Chim Acta. 1969 Aug;25(2):294-6. doi: 10.1016/0009-8981(69)90270-8.
Zotero 插件